More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
Adobe Class Action
Data Breach and Privacy, Existing Cases
On April 3, 2025, Lowey filed a data privacy class action against Adobe, Inc. alleging it used consumers’ personally identifiable information and online activity to create user profiles without obtaining […]
UCSF Class Action
Data Breach and Privacy, Existing Cases
In Doe v. The Regents of the University of California, No. 3:23-cv-00598 (N.D. Cal.), Lowey Dannenberg represents a class of individuals who used the University of California San Francisco Medical […]
News
Lowey Wins Preliminary Approval of Ranbaxy Purchasers’ $145M Settlement
On April 28, 2022 U.S. District Court Judge Nathanial M. Gorton in the District of Massachusetts preliminarily approved one of the largest pharmaceutical antitrust settlements ever recovered on behalf of classes of end-payors. The proposed settlement provides for the...
Blog
Cryptocurrency Exchanges Face Growing Scrutiny from the SEC
Earlier this month, the Securities and Exchange Commission issued a warning to Coinbase Global Inc., the United States’ largest cryptocurrency exchange, based on the exchange’s announced plans to launch its new “Lend” product. The Lend product would allow eligible customers to earn interest on...

